12
Jun

CASE STUDY – Cetrorelix & ISR

Discover how the ImmunoSafe: ISR Platform® support the evaluation of local immune reactions caused by subcutaneous administration of Cetrorelix.

12
Jun

APPLICATION NOTE – ISR

Explore how the ISR Platform® can effectively de-risk your injectable therapeutic candidates today!

12
Jun

APPLICATION NOTE – Non clinical toxicity services

Discover a quick approach to de-risk your injectable therapeutic candidates using ex vivo live human skin.